Use of Cell and Genome Modification Technologies to Generate Improved “Off-the-Shelf” CAR T and CAR NK Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of Cell and Genome Modification Technologies to Generate Improved “Off-the-Shelf” CAR T and CAR NK Cells

Published:2020-08-07 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Morgan Michael A.,Büning Hildegard,Sauer Martin,Schambach Axel

Funder

Deutsche Forschungsgemeinschaft

Deutsche Krebshilfe

Wilhelm Sander-Stiftung

Bundesministerium für Bildung und Forschung

Horizon 2020

European Research Council

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference129 articles.

1. and et al.: graft-versus-leukemia reactions after bone marrow transplantation.;Horowitz;Blood.,1990

2. Adoptive cell transfer: a clinical path to effective cancer immunotherapy.;Rosenberg;Nat Rev Cancer.,2008

3. Signal transduction mediated by the T-cell antigen receptor.;Samelson;Ann N Y Acad Sci.,1995

4. Complex complexes: signaling at the TCR.;Wange;Immunity.,1996

5. The expression of MHC antigens by human teratocarcinoma derived cell lines.;Andrews;Tissue Antigens.,1981

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy;Journal of Translational Medicine;2024-08-05

2. Boosting CAR-T cell therapy with CRISPR technology;hLife;2024-08

3. CAR-T lymphocyte-based cell therapies; mechanistic substantiation, applications and biosafety enhancement with suicide genes: new opportunities to melt side effects;Frontiers in Immunology;2024-07-18

4. Development of glypican-3-specific chimeric antigen receptor-modified natural killer cells and optimization as a therapy for hepatocellular carcinoma;Journal of Leukocyte Biology;2024-06-26

5. Advancing CAR T-cell therapy for chronic lymphocytic leukemia: exploring resistance mechanisms and the innovative strategies to overcome them;Cancer Drug Resistance;2024-05-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3